Four new spin-offs

Four UZH spin-offs were founded last year. Among them, two founding teams could be supported thanks to donations to the UZH Foundation as part of the Entrepreneuer Fellowship.

Last year, four new founding groups with UZH roots took the entrepreneurial leap and signed a licensing agreement with UZH. They came from the Faculty of Medicine, the Vetsuisse Faculty and the Faculty of Science, and have backgrounds in biopharmaceuticals and biomedicine. Their spin-offs bring to market new products or therapies, including a device that tests the quality of donor organs, a drug that combats depression and anxiety, a drug to treat malignant tumors, and immunotherapies to combat cancer.

Two spin-offs, drugs for depression and anxiety and a drug for the treatment of malignant brain tumors, were supported by an Entrepreneur Fellowship of the UZH Innovation Hub. The UZH Foundation supports this Fellowship through donations.

We are excited about the development of the spin-offs and hope to see more such success stories, made possible in part thanks to donations.

Learn more about the four research projects by clicking here.

read more
News

Vitamin D, Omega-3 and Exercise to Prevent Cancer

The international DO-HEALTH study shows that a combination of vitamin D, omega-3 fatty acids and a simple home strength exercise program can significantly reduce the risk of invasive cancer.

read more

read more

UZH Postdoc Team Award Launched Thanks to Donation

The newly introduced UZH Postdoc Team Award is financed through a private donation to the President’s Fund of the UZH Foundation. The award recognizes excellent and independent scientific achievements of interdisciplinary postdoc teams and is worth up to CHF…

read more

read more

Brain Diseases Award 2021 ceremony

Want to learn how eyesight could be restored thanks to the use of optogenetic light sensors? At this year's Brain Diseases Award, which will be presented on November 1, you will gain exciting insights into brain research.

read more